Elanco Animal Health announced that its lifesaving treatment for the deadly canine parvovirus, Canine Parvovirus Monoclonal Antibody, has received full approval from the U.S. Department of Agriculture and will join Elanco’s Tru portfolio under the new brand name Trutect™
Source: Elanco, December 15, 2025. Link. To learn more about Trutect, visit DefeatParvo.com